Erleada

Erleada (Apalutamide) is a prescription medication used to treat certain types of prostate cancer. This oral medication is designed to help manage cancer progression in specific cases.

Erleada is primarily used in the treatment of prostate cancer. It is often prescribed for non-metastatic castration-resistant prostate cancer, helping to delay the spread of the disease. Patients typically use Erleada as part of a broader treatment plan, which may include other medications or therapies. The specific uses of Erleada should be determined by a healthcare provider based on individual patient needs.

Common effects of Erleada may include fatigue, rash, and nausea. Some patients may experience joint pain or swelling. It is important to discuss any persistent or severe side effects with a healthcare provider. Individual responses to the medication can vary, and not all patients will experience the same effects.

Erleada should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare provider. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions. Pregnant women or those planning to become pregnant should avoid handling Erleada due to potential risks.

Erleada may interact with certain medications, including those metabolized by the liver's CYP2C8 and CYP3A4 enzymes. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol consumption should be discussed with a healthcare provider, as it may affect the efficacy or safety of Erleada.